Susquehanna International Group’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-7,200
Closed -$103K – 12237
2023
Q4
$103K Hold
7,200
– – ﹤0.01% 11309
2023
Q3
$93.2K Hold
7,200
– – ﹤0.01% 10977
2023
Q2
$144K Buy
+7,200
New +$157K ﹤0.01% 10615
2023
Q1
– Sell
-516
Closed -$18.1K – 12618
2022
Q4
$18.1K Hold
516
– – ﹤0.01% 11794
2022
Q3
$34K Hold
516
– – ﹤0.01% 12407
2022
Q2
$39K Sell
516
-514
-50% -$35.1K ﹤0.01% 12104
2022
Q1
$89K Sell
1,030
-479
-32% -$45.6K ﹤0.01% 11984
2021
Q4
$193K Sell
1,509
-7
-0.5% -$1.36K ﹤0.01% 11484
2021
Q3
$352K Buy
1,516
+342
+29% +$96.1K ﹤0.01% 10231
2021
Q2
$446K Buy
+1,174
New +$385K ﹤0.01% 9856

Other funds holding CALC

Susquehanna International Group's CALC Position: Q2 2026 in Review

Susquehanna International Group increased its CalciMedica (CALC) stake by 43% in Q2 2026, buying an estimated $9.4K and bringing the position to 8,794 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12862.

Susquehanna International Group first reported a position in CALC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.46M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Susquehanna International Group held 8,794 shares of CalciMedica worth $45.3K as of Q2 2026.
  • Susquehanna International Group bought 2,651 CalciMedica shares in Q2 2026, an estimated $9.4K.
  • CalciMedica made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12862 holding.
  • Susquehanna International Group first reported a position in CalciMedica in Q2 2021 and has held it in 7 quarters since.
  • Susquehanna International Group's CalciMedica position peaked at $1.46M in Q2 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.